Sanaa: The Central Military Court issued its verdict in Case No. 27 of 1445 AH against Ahmed Ali Abdullah Saleh Afash. The court found him guilty of treason, espionage, and collaborating with the enemy, as well as corruption charges. The ruling senten…
Month: July 2025
Inspection Conducted at Al-Tayeb Hospital and Progress Observed on Doctors’ Housing Project in Sabah District
Al-bayda: The Deputy Governor of Al-Bayda for Health Affairs, Nasser Al-Ajji, conducted an inspection visit on Thursday to assess the performance and medical services at Al-Tayeb Rural Hospital in Sabah District.
According to Yemen News Agency, dur…
Hodeida: Women’s Organization in Ad-Dahi Holds Cultural Seminar on Imam Al-Hadi’s Arrival Anniversary
Hodeida: The Women’s Organization in Ad-Dahi District, Al-Hodeida Governorate, held a cultural seminar commemorating the arrival of Imam Al-Hadi ila al-Haqq Yahya bin Al-Hussein, under the slogan “Imam of Knowledge and Jihad.”
According to Yemen New…
Leader Urges Yemeni Citizens to Support Palestinian Cause with Mass Rallies
Sana’a: Leader of the Revolution Sayyed Abdulmalik Badr al-Din al-Houthi has called upon the Yemeni populace to participate in large-scale rallies on Friday in the capital, Sana’a, and other governorates. The call aims to express solidarity with the P…
DebitMyData Closes Oversubscribed Seed Round- Launches $1B Human Energy Grid Global Expansion
Seed raise exceeding 200% of target positions the DebitMyData Digital Identity LLM (DID-LLM) for Global Partnerships and Licensing DebitMyData Logo FORT LAUDERDALE, Fla., July 30, 2025 (GLOBE NEWSWIRE) — DebitMyData, Inc.—the powerhouse has closed a seed round at more than twice its original target. This surge of investor confidence paves the way for a bold, […]
Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development
Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis Dr. Falk Pharma GmbH, a research-based pharmaceutical company specializing in digestive and metabolic medicine, Allianthera (Suzhou) Biopharmaceuticals Co., […]